Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells

Current Pharmaceutical Design

Volumn 20, Issue 33, 2014, Pages 5348-5353

  Xia, Jun ^a   Cheng, Long ^a   Mei, Chuanzhong ^a   Ma, Jia ^a   Shi, Ying ^a   Zeng, Fanpeng ^a   Wang, Zhenghuan ^a   Wang, Zhiwei ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Cell growth; FOXO1; Genistein; MiR 27a; Pancreatic cancer

Indexed keywords

GENISTEIN; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN27 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION ASSAY; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MTT ASSAY; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENETICS; METABOLISM; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENISTEIN; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84908183103     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140128215756     Document Type: Article

References (31)

1. Banerjee S, Li Y, Wang Z, Sarkar F H. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226-42.
2. Nagaraju G P, Zafar S F, El-Rayes B F. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev 2013; 71: 562-72.
3. Pan H, Zhou W, He W, et al. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kappa B activity via the Notch-1 pathway. Int J Mol Med 2012; 30: 337-43.
4. Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar F H. Inactivation of NF-kappa B by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003; 22: 4702-9.
5. Bao B, Wang Z, Ali S, et al. Over-expression of Fox M1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 2011; 112: 2296-306.
6. Li Y, Wang Z, Kong D, et al. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 2008; 283: 27707-16.
7. Bao B, Wang Z, Ali S, et al. Notch-1 induces epithelialmesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011; 307: 26-36.
8. Calin G A, Croce C M. Micro RNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
9. Kasinski A L, Slack F J. Epigenetics and genetics. Micro RNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-64.
10. van Kouwenhove M, Kedde M, Agami R. Micro RNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011; 11: 644-56.
11. Mertens-Talcott S U, Chintharlapalli S, Li X, Safe S. The oncogenic micro RNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDAMB-231 breast cancer cells. Cancer Res 2007; 67: 11001-11.
12. Liu T, Tang H, Lang Y, Liu M, Li X. Micro RNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009; 273: 233-42.
13. Zhao X, Yang L, Hu J. Down-regulation of mi R-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res 2011; 30: 55.
14. Zhang H, Li M, Han Y, et al. Down-regulation of mi R-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 2010; 55: 2545-51.
15. Wang Q, Li D C, Li Z F, et al. Upregulation of mi R-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 2011; 30: 3875-86.
16. Liao S, Xia J, Chen Z, et al. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NFkappa B signaling pathways. J Cell Biochem 2011; 112: 1055-65.
17. Xia J, Duan Q, Ahmad A, et al. Genistein inhibits cell growth and induces apoptosis through up-regulation of mi R-34a in pancreatic cancer cells. Curr Drug Targets 2012; 13: 1750-6.
18. Ma J, Cheng L, Liu H, et al. Genistein down-regulates mi R-223 expression in pancreatic cancer cells. Curr Drug Targets 2013; 14: 1150-6.
19. Wang W S, Liu L X, Li G P, et al. Combined serum CA19-9 and mi R-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res (Phila) 2013; 6: 331-8.
20. Li Y, Vandenboom T G, 2nd, Wang Z, et al. mi R-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010; 70: 1486-95.
21. Majid S, Dar A A, Saini S, et al. Regulation of minichromosome maintenance gene family by micro RNA-1296 and genistein in prostate cancer. Cancer Res 2010; 70: 2809-18.
22. Chen Y, Zaman M S, Deng G, et al. Micro RNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 2011; 4: 76-86.
23. Hirata H, Ueno K, Nakajima K, et al. Genistein downregulates onco-mi R-1260b and inhibits Wnt-signalling in renal cancer cells. Br J Cancer 2013.
24. Chiyomaru T, Yamamura S, Fukuhara S, et al. Genistein Up-Regulates Tumor Suppressor Micro RNA-574-3p in Prostate Cancer. PLo S One 2013; 8: e58929.
25. Chiyomaru T, Yamamura S, Zaman M S, et al. Genistein suppresses prostate cancer growth through inhibition of oncogenic micro RNA-151. PLo S One 2012; 7: e43812.
26. Zaman M S, Shahryari V, Deng G, et al. Up-regulation of micro RNA-21 correlates with lower kidney cancer survival. PLo S One 2012; 7: e31060.
27. Ma Y, Yu S, Zhao W, Lu Z, Chen J. mi R-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett 2010; 298: 150-8.
28. Sun Q, Cong R, Yan H, et al. Genistein inhibits growth of human uveal melanoma cells and affects micro RNA-27a and target gene expression. Oncol Rep 2009; 22: 563-7.
29. Xu L, Xiang J, Shen J, et al. Oncogenic Micro RNA-27a is a target for genistein in ovarian cancer cells. Anticancer Agents Med Chem 2013; 13: 1126-32.
30. Zhou L, Yin B, Liu Y, et al. Mechanism and function of decreased FOXO1 in renal cell carcinoma. J Surg Oncol 2012; 105: 841-7.
31. Kousteni S. Fox O1: a molecule for all seasons. J Bone Miner Res 2011; 26: 912-7.